Vivani Medical Inc. (VANI)
1.13
-0.02 (-1.74%)
At close: Mar 28, 2025, 3:38 PM
1.14
1.32%
After-hours: Mar 28, 2025, 05:40 PM EDT
-1.74% (1D)
| Bid | 1.04 |
| Market Cap | 66.64M |
| Revenue (ttm) | 555.39K |
| Net Income (ttm) | -25.16M |
| EPS (ttm) | -0.43 |
| PE Ratio (ttm) | -2.62 |
| Forward PE | -2.1 |
| Analyst | Buy |
| Ask | 1.17 |
| Volume | 180,570 |
| Avg. Volume (20D) | 93,653 |
| Open | 1.15 |
| Previous Close | 1.15 |
| Day's Range | 1.05 - 1.13 |
| 52-Week Range | 1.03 - 2.22 |
| Beta | 3.50 |
About VANI
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California....
Industry Medical - Devices
Sector Healthcare
IPO Date Nov 19, 2014
Employees 36
Stock Exchange NASDAQ
Ticker Symbol VANI
Website https://www.vivani.com
Analyst Forecast
According to 1 analyst ratings, the average rating for VANI stock is "Buy." The 12-month stock price forecast is $4, which is an increase of 255.56% from the latest price.
Stock Forecasts
